Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction

被引：6
作者：
Lobbes, M. B. I. [1 ,2 ]
机构：
[1] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands
[2] GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2012年 / 136卷 / 01期
关键词：
ACCURACY; SIZE;
D O I：
10.1007/s10549-012-2180-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 314
页数：2
相关论文
共 12 条
[1]   MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy [J].
Belli, P. ;
Costantini, M. ;
Malaspina, C. ;
Magistrelli, A. ;
LaTorre, G. ;
Bonomo, L. .
CLINICAL RADIOLOGY, 2006, 61 (11) :946-953
[2]   MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy [J].
Chen, Jeon Hor ;
Feig, Lyon ;
Agrawal, Garima ;
Yu, Hon ;
Carpenter, Philip M. ;
Mehta, Rita S. ;
Nalcioglu, Orhan ;
Su, Min Ying .
CANCER, 2008, 112 (01) :17-26
[3]   Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI [J].
Cheung, YC ;
Chen, SC ;
Su, MY ;
See, LC ;
Hsueh, S ;
Chang, HK ;
Lin, YC ;
Tsai, CS .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) :51-58
[4]   Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer [J].
Denis, F ;
Desbiez-Bourcier, AV ;
Chapiron, C ;
Arbion, F ;
Bodyd, G ;
Brunereau, L .
EJSO, 2004, 30 (10) :1069-1076
[5]  
Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1
[6]   Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI [J].
Kim, Hyun Jung ;
Im, Young-Hyuck ;
Han, Boo-Kyung ;
Choi, Nami ;
Lee, Jeeyun ;
Kim, Jung Han ;
Choi, Yoon-La ;
Ahn, Jin-Seok ;
Nam, Seok-Jin ;
Park, Young Suk ;
Choe, Yeon Hyeon ;
Ko, Young-Hyeh ;
Yang, Jung-Hyun .
ACTA ONCOLOGICA, 2007, 46 (07) :996-1003
[7]   Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype [J].
Loo, Claudette E. ;
Straver, Marieke E. ;
Rodenhuis, Sjoerd ;
Muller, Sara H. ;
Wesseling, Jelle ;
Peeters, Marie-Jeanne T. F. D. Vrancken ;
Gilhuijs, Kenneth G. A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) :660-666
[8]   MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes [J].
Nakahara, Hiroshi ;
Yasuda, Yukiko ;
Machida, Eiichiro ;
Maeda, Yorio ;
Furusawa, Hidemi ;
Komaki, Kansei ;
Funagayama, Mayumi ;
Nakahara, Mayumi ;
Tamura, Shozo ;
Akiyama, Futoshi .
BREAST CANCER, 2011, 18 (03) :152-160
[9]   Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy [J].
Partridge, SC ;
Gibbs, JE ;
Lu, Y ;
Esserman, LJ ;
Sudilovsky, D ;
Hylton, NM .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (05) :1193-1199
[10]   Does MRI predict pathologioc tumor response in women with breast cancer undergoing preoperative chemotherapy? [J].
Segara, Davendra ;
Krop, Ian E. ;
Garber, Judy E. ;
Winer, Eric ;
Harris, Lyndsay ;
Bellon, Jennifer R. ;
Birdwell, Robyn ;
Lester, Susan ;
Lipsitz, Stuart ;
Iglehart, J. Dirk ;
Golshan, Mehra .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (06) :474-480
12